Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and fedratinib

erlotinib hydrochloride has been researched along with fedratinib in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(fedratinib)		Trials
(fedratinib)		Recent Studies (post-2010) (fedratinib)
4,3537863,03312016111

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)fedratinib (IC50)
Cyclin-G-associated kinaseHomo sapiens (human)0.001
Tyrosine-protein kinase JAK2Homo sapiens (human)0.0035
Bromodomain-containing protein 4Homo sapiens (human)0.29
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.0325
Tyrosine-protein kinase JAK1Homo sapiens (human)0.053
Non-receptor tyrosine-protein kinase TYK2Homo sapiens (human)0.078
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.02
Tyrosine-protein kinase JAK3Homo sapiens (human)0.3917
AP2-associated protein kinase 1Homo sapiens (human)0.032
Bromodomain testis-specific proteinHomo sapiens (human)0.34

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YB; Duan, SZ; Xia, YC; Yang, WT; Zhang, FQ; Zhu, RY1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and fedratinib

ArticleYear
JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.
    Oncotarget, 2015, Jun-10, Volume: 6, Issue:16

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Janus Kinase 2; Lung Neoplasms; Mice; Mice, Nude; Pyrrolidines; Sulfonamides; Xenograft Model Antitumor Assays

2015